Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis
par Moreau, Anthony 
;Nicaise, Charles ;Awada, Ahmad ;Soyfoo, Muhammad Shahnawaz
Référence Clinical and Experimental Rheumatology, 40, 5, page (897-903)
Publication Publié, 2022-05-01
;Nicaise, Charles ;Awada, Ahmad ;Soyfoo, Muhammad Shahnawaz Référence Clinical and Experimental Rheumatology, 40, 5, page (897-903)
Publication Publié, 2022-05-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Moreau, Anthony; Nicaise, Charles; Awada, Ahmad; Soyfoo, Muhammad Shahnawaz |
| Informations sur la publication: | Clinical and Experimental Rheumatology, 40, 5, page (897-903) |
| Statut de publication: | Publié, 2022-05-01 |
| Sujet CREF: | Immunologie |
| Rhumatologie | |
| Allergie et immunopathologie | |
| Mots-clés: | interleukin-33 |
| lupus nephritis | |
| soluble ST2 | |
| systemic lupus erythematosus | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0392-856X |
| info:doi/10.55563/clinexprheumatol/eg3a2k | |
| info:scp/85130646052 | |
| info:pmid/34128798 |
